Deborah Phippard, PhD, and Renier Brentjens, MD, PhD, came together for a wide-spanning discussion around the successes and progress, as well as the obstacles faced by cell and gene therapy development and uptake since 2000.
News Network
Experts explore the clinical significance and practical implications of recent findings regarding a CAR T-cell therapy in real-world settings.
Expert perspectives from Amod Sarnaik, MD, and Krishna Komanduri, MD, on the evolving role of tumor-infiltrating lymphocyte therapy in solid tumors, following the Society for Immunotherapy of Cancer (SITC) 2022 meeting.
Experts review key updates in LBCL management from the ASH 2022 annual meeting.
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
